Concord Drugs Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Concord Drugs Limited Company Profile :

Concord Drugs Limited is an Indian pharmaceutical company which is engaged in the manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ), Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets.


Concord Drugs ResultsBSE Code : 538965
NSE Symbol :
ISIN No. : INE858L01010
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Concord Drugs or you are an stock market analyst then i am sure you might for Quarterly Results of Concord Drugs.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Concord Drugs. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Concord Drugs.

Concord Drugs Ltd Q1 Results 2016-17 :

Concord Drugs will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Concord Drugs will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Concord Drugs will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Concord Drugs will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Concord Drugs will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure  –
Interest  –
Depreciation  –
PBT  –
Tax  –
Net Profit  –
Equity  –
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Concord Drugs Ltd Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 50.89
Other Income  –  –
Total Income  50.89  –
Expenditure  -42.44  –
Interest  -2.57  –
Depreciation  -2.91  –
PBT  2.96  –
Tax  -0.87  –
Net Profit  2.09  –
Equity  7.24  –
EPS  2.89  –

Note : If you like this information about Concord Drugs Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.